Target Audience

This educational program has been developed to provide hematology specialists based outside of the USA with a comprehensive overview of the recent advances in the treatment of hematologic malignancies from an International perspective.

Speakers


Irene Ghobrial, MD                                

Dana Farber Cancer Institute

Boston, Massachusetts, United States      

 

Andreas Hochhaus, MD               

University of Heidelberg

Mannheim, Germany

 

Sagar Lonial, MD

Winship Cancer Institute

Atlanta, Georgia, United States

 

Enrique M. Ocio, MD, PhD

University Hospital of Salamanca

Salamanca, Spain

Agenda

8:00 PM




Welcome and Introduction



8:10 PM






Imatinib Resistant/Intolerant CML:  A Model for Successful Intervention with Secondary Targeted Therapy
Andreas Hochhaus, MD


8:30 PM


Ask the Experts


8:35 PM






Histone Deacetylase Inhibitors (HDACs):  A Novel Option in Refractory Multiple Myeloma
Enrique M. Ocio, MD, PhD


8:55 PM


Ask the Experts


9:00 PM






Defining the issues and rising to the challenge in the treatment of relapsed and refractory Waldenstrom’s Macroglobulinemia
Irene Ghobrial, MD


9:20 PM


Ask the Experts


9:25 PM 





Novel approaches in the management of relapsed and refractory Hodgkin’s and non-Hodgkin’s lymphoma: From concept to reality
Sagar Lonial, MD


9:45 PM



Ask the Experts
9:50 PM




Symposium Summary and Concluding Remarks



 















     

Supporters


This activity is supported by Novartis Oncology